Teenage Smoking Rate Decreased, but E-cigarette Use Increased

Aug.21.2023
Teenage Smoking Rate Decreased, but E-cigarette Use Increased
Teenage smoking rates decline during COVID-19, but e-cigarette use increases, alcohol consumption remains stable, and mental health deteriorates.

According to a recent survey conducted by the Korea Centers for Disease Control and Prevention (KCDC), the overall smoking rate among teenagers has decreased in the past two years since the outbreak of COVID-19. The survey, titled the "17th Youth Health Behavior Survey," collected data from approximately 60,000 students from middle school first grade to high school third grade between August and November last year.

 

The statistics revealed that the smoking and drinking habits of teenagers remained stable in 2020, after experiencing a significant drop compared to 2019, the year before the COVID-19 pandemic. The percentage of teenagers who reported smoking cigarettes for more than one day in the past month was 4.5%, a similar level to the previous year (4.4%), and lower than the pre-pandemic rate of 6.7% in 2019.

 

The KCDC attributed this trend to the increase in remote learning and the decrease in peer gatherings during the pandemic period. However, the use of e-cigarettes increased, with the usage rates of liquid-type e-cigarettes rising from 1.9% to 2.9% in a year, and cartridge-type e-cigarettes increasing from 1.1% to 1.4%.

 

In terms of alcohol consumption, the percentage of teenagers who reported drinking at least one glass in the past 30 days remained the same at 10.7%. The "current drinking rate" also showed no significant increase since it dropped from 15.0% in 2019 to 10.7% in 2020.

 

While the average alcohol consumption rate in the past month decreased slightly from 5.2% in 2020 to 4.9% in 2021, indicating a decline in risky drinking behaviors, the accessibility to purchase tobacco and alcohol increased. The percentage of teenagers who reported that they could easily buy cigarettes or alcohol from convenience stores or shops increased significantly compared to the previous year, with the accessibility rate for cigarette purchases rising from 67.0% to 74.8% and for alcohol purchases from 63.5% to 71.3%.

 

While the percentage of teenagers engaging in regular physical activities increased slightly to 14.6% who participated in at least 60 minutes of physical activity for five or more days a week, the dietary habits did not improve. The percentage of teenagers skipping breakfast for five or more days a week continued to rise, reaching 38.0% in 2021, compared to 27.9% in 2015. Additionally, the percentage of teenagers consuming fruits decreased for the fifth consecutive year, recording 18.1% in 2021.

 

Mental health indicators also worsened in 2021 compared to the previous year. The prevalence of depression increased from 25.2% in 2020 to 26.8%, and the perceived stress rate rose from 34.2% to 38.8%. Females showed higher rates of depression (31.4%) and stress (45.6%) compared to males (22.4% and 32.3% respectively).

 

In conclusion, while the smoking rate among teenagers has decreased during the COVID-19 pandemic, the use of e-cigarettes has increased. Additionally, there has been no significant change in alcohol consumption, but the accessibility to purchase tobacco and alcohol has increased. Furthermore, despite a slight increase in regular physical activity, detrimental dietary habits and worsening mental health indicators are concerning issues among teenagers.


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Vaping prevalence in Great Britain edged down to 9.9% in 2025 from 10.0% in 2024, with the number of adult users holding at approximately 5.4 million for a second consecutive year, according to the Office for National Statistics (ONS). E-cigarette use had risen from 6.4% in 2020 to 10.0% in 2024, when it exceeded cigarette smoking prevalence for the first time. Cigarette smoking continued to decline to 8.7% in 2025, widening the gap to 1.2 percentage points. Daily vaping declined slightly, while usage among adults aged 25–34 increased despite falling rates in other age groups.
DATA
Oct.14
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs Seizes PHP11.68 Billion($200 Million) in Illegal Tobacco and Vapes in First Seven Months of 2026
Philippines Customs data showed that illegal cigarettes and vape products seized during the first seven months of 2026 were valued at about PHP11.68 billion, exceeding the PHP2.516 billion recorded for the full year of 2025. The figures were disclosed by a Bureau of Customs official during a House Committee on Ways and Means hearing on tobacco excise tax reforms. Vape-related seizures were valued at about PHP1.65 billion, with most cases recorded at the Manila International Container Port. Customs officials said enforcement against illicit tobacco trade would continue.
Aug.26
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28